Companies:
52,897
Total Market Cap:
163057471104254.97
Global Rank
#52074
Country Rank
#6486
Market Cap
72,757
Price
6.86
Change (%)
24.86%
Volume
318,810
Onconetix's latest marketcap:
72,757
As of 11/07/2026, Onconetix's market capitalization has reached $72,757. According to our data, Onconetix is the 52074th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 72,757 |
| Revenue (ttm) | 645,824 |
| Net Income (ttm) | -10,196,193 |
| Shares Out | 69,292 |
| EPS (ttm) | -171.56 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 11/20/2026 |
Market Cap Chart
Data Updated: 11/07/2026
Onconetix's yearly market capitalization.
Onconetix has seen its market value drop from $17.02 M to $72,757 since 2022, representing a total decrease of 99.57% and an annual compound decline rate (CAGR) of 75.71%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 11/07/2026 | $72,757 | 11.03% | 52074 |
| 12/31/2025 | $2.43 M | -53.56% | 43185 |
| 12/31/2024 | $5.22 M | 43.7% | 40731 |
| 12/29/2023 | $3.64 M | -78.64% | 40491 |
| 12/30/2022 | $17.02 M | 33489 |
Company Profile
About Onconetix, Inc.
Onconetix, Inc. is a biotechnology company dedicated to advancing research, development, and commercialization of innovative solutions in men’s health and oncology.
Key Offerings
- Entadfi: An FDA-approved, once-daily pill combining finasteride and tadalafil for treating benign prostatic hyperplasia (BPH).
- Proclarix: A protein-based in vitro blood diagnostic test designed for prostate cancer detection.
Company Background
Formerly known as Blue Water Biotech, Inc., the company rebranded as Onconetix, Inc. in December 2023. Founded in 2018, Onconetix is headquartered in Cincinnati, Ohio.
Frequently Asked Questions
-
What is Onconetix's (ONCO) current market cap?As of 11/07/2026, Onconetix (including the parent company, if applicable) has an estimated market capitalization of $72,757 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Onconetix (ONCO) rank globally by market cap?Onconetix global market capitalization ranking is approximately 52074 as of 11/07/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.